Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept

Colorectal cancer is the second leading cause of cancer-related death worldwide. For metastatic colorectal cancer (mCRC) patients, it is recommended, as first-line treatment, chemotherapy (CT) based on doublet cytotoxic combinations of fluorouracil, leucovorin, and irinotecan (FOLFIRI) and fluoroura...

Descripción completa

Detalles Bibliográficos
Autores principales: González Astorga, B., Salvà Ballabrera, F., Aranda Aguilar, E., Élez Fernández, E., García-Alfonso, P., González Flores, E., Vera García, R., Fernández Montes, A., López Muñoz, A. M., Salud Salvia, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238745/
https://www.ncbi.nlm.nih.gov/pubmed/33630242
http://dx.doi.org/10.1007/s12094-021-02568-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238745/
https://www.ncbi.nlm.nih.gov/pubmed/33630242
http://dx.doi.org/10.1007/s12094-021-02568-y

Ejemplares similares